Company

Provention Bio, Inc.

Provention Bio, Inc. is a Red Bank, US biopharma developing therapies for autoimmune and inflammatory diseases.

About

Founded in 2016 and based in Red Bank, US, Provention Bio, Inc. is a biopharmaceutical company developing therapeutics to prevent autoimmune and inflammatory diseases, including type 1 diabetes, celiac disease and lupus. In March 2023, Sanofi S.A. agreed to acquire the company for approximately USD 2.9 billion in equity, at USD 25 per share in cash. Ashleigh Palmer is co-founder and CEO.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in